C12N 2770/32151
Methods of production or purification of viral material
C12N2770/32151 (Methods of production or purification of viral material) appears on 21 US grants and 24 published applications in this corpus.
Search patents in C12N- Granted patents
- 21
- Published applications
- 24
- Assignees
- 16
- Inventors
- 76
- Latest grant
- 18 Mar 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 1 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 1 |
| 2015 | 2 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 3 |
| 2019 | 3 | 8 |
| 2020 | 6 | 0 |
| 2021 | 4 | 2 |
| 2022 | 0 | 3 |
| 2023 | 0 | 1 |
| 2024 | 1 | 3 |
| 2025 | 1 | 0 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Engineered Hansenula fungi efficiently expressing CA10 virus-like particles and uses thereof18 Mar 2025US 12,251,435 B2Beijing Minhai Biotechnology Co., Ltd.
- Recombinant foot-and-mouth disease virus with reduced immunosuppression activity, and preparation method and use thereof9 Apr 2024US 11,952,401 B2Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences
- Method of purifying virus-like-particles7 Dec 2021US 11,191,824 B1The Government of the United States of America, as represented by the Secretary of Homeland Security
- Stabilised FMDV capsids6 Jul 2021US 11,053,286 B2The Pirbright Institute
- Method for preparing foot-and-mouth disease vaccines25 May 2021US 11,013,794 B2
- Method of producing a foot and mouth disease virus virus-like particle21 Nov 2024US 2024/0382579 A1Intervet Inc.
- Method of producing a foot and mouth disease virus virus-like particle31 Oct 2024US 2024/0358815 A1Intervet Inc.
- Fmdv virus-like particle with stabilizing mutation31 Oct 2024US 2024/0358816 A1Intervet Inc.
- Baculovirus expression vector14 Dec 2023US 2023/0399363 A1Intervet Inc.
- Hansenula engineering fungi efficiently expressing ca10 virus-like particles and use thereof21 Apr 2022US 2022/0118075 A1Beijing Minhai Biotechnology Co., Ltd.
Most cited
By later US patents
- Vaccines, the process for preparing the same and the applications thereof26US 3,983,229 AAgence Nationale de Valorisation de la Recherche (ANVAR) · 1976
- Modified foot-and-mouth disease virus 3C proteases, compositions and methods thereof6US 10,385,319 B2The Governement of the United States of America, as represented by the Secretary of Homeland Security · 2019
- Method for preserving viral particles6US 8,313,897 B2Stabilitech Ltd. · 2012
- Processing of a modified foot-and-mouth disease virus P1 polypeptide by an alternative protease3US 10,308,927 B2The United States of America, as represented by the Secretary of Homeland Security · 2019
- Process for preparing vaccine3US 4,085,203 ABurroughs Wellcome Co. · 1978